SCHEMBL224441

SCHEMBL224441

O=C(CCl)NC1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL854700 0.91 MTNR1A (0.45)
SCHEMBL943151 0.91 EPHX2 (0.58)
SCHEMBL943150 0.91 EPHX2 (0.58)
SCHEMBL854701 0.91 MTNR1A (0.45)
SCHEMBL4303783 0.90
SCHEMBL3453982 0.90 SMN1; SMN2 (0.61)
SCHEMBL11625924 0.89 EPHX1 (0.52)
SCHEMBL9797827 0.89 KMT2A (0.59)
SCHEMBL19706964 0.89 SMYD3 (0.49)
SCHEMBL227416 0.88 EPHX1 (0.61)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 347 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101928265-A 1-(cinnamoyl)-4-alkyl amide piperazine compound and preparation method thereof KAIZHI XIE 2010-12-29 CN claimed
EP-1243581-B1 Pyridinium compounds useful for the treatment of AGE-related diseases TORRENT PHARMACEUTICALS LTD (IN) 2005-07-13 EP claimed
US-6608094-B2 Breaking preformed AGE TORRENT PHARMACEUTICALS LTD. (IN) 2003-08-19 US claimed
US-20260034127-A1 TREATMENT OF GVHD KADMON CORP LLC (FR) 2026-02-05 US disclosed
US-20250361236-A9 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS GILEAD SCIENCES INC (US) 2025-11-27 US disclosed
US-12454524-B2 (r)-n-(4-(chlorodifluoromethoxy)phenyl)-2-(difluoromethyl)-1-(1-hydroxypropan-2-yl)-7-(pyrimidin-5-yl)-1H-benzo[d]imidazole-5-carboxamide, or a pharmaceutically acceptable salt or tautomer thereof, for treating certain leukemias TERNS PHARMACEUTICALS, INC. (US) 2025-10-28 US disclosed
US-20250276961-A1 COMPOUNDS FOR TREATING CERTAIN LEUKEMIAS Terns, Inc. 2025-09-04 US disclosed
US-12404269-B2 Aminoquinazolinone and aminoisoquinolinone derivatives and application thereof ZHEJIANG UNIVERSITY (CN) 2025-09-02 US disclosed
US-20250243184-A1 COMPOUNDS FOR TREATING CERTAIN LEUKEMIAS Terns, Inc. 2025-07-31 US disclosed
US-20250136598-A1 SUBSTITUTED PYRAZOLO-PYRIDINE AMIDES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2025-05-01 US disclosed
CN-115448908-B Compounds for the treatment of specific leukemias 拓臻股份有限公司 2025-04-25 CN disclosed
EP-0728748-A1 NOVEL BENZODIAZEPINE DERIVATIVE SHIONOGI & CO., LTD. (JP) 1996-08-28 EP disclosed
WO-1995030644-A1 AMIDE DERIVATIVES AND THEIR THERAPEUTIC USE THE WELLCOME FOUNDATION LIMITED (GB) 1995-11-16 WO disclosed
WO-1994026692-A1 BICYCLIC AMIDE DERIVATIVES AND THEIR USE AS MUSCLE RELAXANTS THE WELLCOME FOUNDATION LIMITED (GB) 1994-11-24 WO disclosed
EP-0569409-A1 AMIDE DERIVATIVES AND THEIR THERAPEUTIC USE THE WELLCOME FOUNDATION LIMITED (GB) 1993-11-18 EP disclosed
WO-1992012959-A1 AMIDE DERIVATIVES AND THEIR THERAPEUTIC USE THE WELLCOME FOUNDATION LIMITED (GB) 1992-08-06 WO disclosed
US-4499100-A CARDIOUVASCULAR DISORDERS SYNTEX (U.S.A.) INC. (US) 1985-02-12 US disclosed
EP-0000023-B1 OMEGA-SUBSTITUTED PENTYL UREAS, THEIR PREPARATION AND THEIR USE AS FUNGICIDES BAYER AG (DE) 1980-07-23 EP disclosed
US-4188401-A Combating fungi with 1-(ω-substituted pentyl)-3-(2-cyano-acetyl)-ureas BAYER AKTIENGESELLSCHAFT (DE) 1980-02-12 US disclosed
EP-0000023-A1 Omega-substituted pentyl ureas, their preparation and their use as fungicides BAYER AG (DE) 1978-12-20 EP disclosed